Skip to content

A comparison of isobaric versus hypobaric plus isobaric drugs in segmental thoracic spinal anaesthesia for reducing shoulder pain during laparoscopic cholecystectomy

A randomized controlled trial comparing isobaric versus hypobaric plus isobaric drug in segmental thoracic spinal for reducing shoulder pain during laparoscopic cholecystectomy - BARIC-LC

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076271
Enrollment
60
Registered
2024-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Thoracic Segmental Spinal injection: Thoracic spinal anesthesia at T9-T10 Control Intervention1: Thoracic Segmental Spinal injection of Isobaric bupivacaine + Dexmedetomidine .: Thoraci

Sponsors

RMCH BAREILLY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 20 to 70 years, with ASA physical status I-II, scheduled for elective laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: ASA III-V, BMI more than 35, contraindications to regional anesthesia e.g., local infection, coagulopathy, allergy to study drugs, and spinal abnormalities e.g. kyphosis, scoliosis.

Design outcomes

Primary

MeasureTime frame
Primary Outcome: Shoulder pain assessed using a visual analog scale (VAS) during surgery, at the end of surgery, and at 2, 6, 12, and 24 hours postoperatively. Timepoint: T1 : Intraop T2 : 2hrs Post Op T6 : 6 Hrs Post Op T12 : 12 Hrs Post Op T24 : 24 Hrs Post Op

Secondary

MeasureTime frame
Secondary Outcomes: Total intraoperative and postoperative analgesic use. Time to first analgesic request. Incidence of adverse effects (hypotension, bradycardia, nausea, vomiting). Patient satisfaction score at 24 hours post-surgery.Timepoint: T1 : Intraop Ta : Time to first analgesic request T24 : 24 Hrs Post Op

Countries

India

Contacts

Public ContactAnmol Singh

IPGME&R SSKM Kolkata

dranmolsinghchd@gmail.com7009061716

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026